(Q34591803)

3 August 2017

1 reference

title

Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? (English)

1 reference

3 August 2017

0 references

1 reference

Harold Bays

1

1 reference

3 August 2017

Lawrence Blonde

series ordinal

2

1 reference

3 August 2017

Robert Rosenson

series ordinal

3

1 reference

3 August 2017

publication date

1 November 2006

1 reference

Expert Review of Cardiovascular Therapy

3 August 2017

published in

1 reference

3 August 2017

volume

4

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

871-895

1 reference

Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Adiposopathy: why do adiposity and obesity cause metabolic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Current and investigational antiobesity agents and obesity therapeutic treatment targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Adiposopathy is a more rational treatment target for metabolic disease than obesity alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The role of the endocannabinoid system in the control of energy homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The endocannabinoid system and the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

cAMP-positive regulation of angiotensinogen gene expression and protein secretion in rat adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Development of the multiple metabolic syndrome in the ARIC cohort: joint contribution of insulin, BMI, and WHR. Atherosclerosis risk in communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The influence of physical activity on abdominal fat: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Obesity, Metabolic Syndrome, and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Insulin resistance and the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Once‐Daily Niacin Extended Release/Lovastatin Combination Tablet Has More Favorable Effects on Lipoprotein Particle Size and Subclass Distribution Than Atorvastatin and Simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Diabetes, lipids, and adipocyte secretagogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Free fatty acids, insulin resistance, and corrected qt intervals in morbid obesity: effect of weight loss during 6 months with differing dietary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Metabolic changes induced by combined prolonged exercise and low-calorie intake in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of weight-loss by exercise and by diet on apolipoproteins A-I and A-II and the particle-size distribution of high-density lipoproteins in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Low-density lipoprotein density and atherosclerosis. Unraveling the connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Lipids and glucose in type 2 diabetes: what is the cause and effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The effects of orlistat on metabolic parameters and other cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Mechanism of insulin-resistant glucose transport activity in the enlarged adipose cell of the aged, obese rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Weight loss in obese diabetic and non-diabetic individuals and long-term diabetes outcomes--a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of dietary modification and treatment of obesity. Emphasis on improving vascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effect of a short-term diet and exercise intervention on metabolic syndrome in overweight children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effect of voluntary exercise on peripheral tissue glucocorticoid receptor content and the expression and activity of 11beta-HSD1 in the Syrian hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Critical review of acylation-stimulating protein physiology in humans and rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Acylation-stimulating protein: effect of acute exercise and endurance training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Serum adiponectin concentrations during a 72-hour fast in over- and normal-weight humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Lack of increase of serum adiponectin concentrations with a moderate weight loss during six months on a high-caloric diet in military service among a young male Finnish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Plasma adiponectin levels and blood pressures in nondiabetic adolescent females

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Factors that influence the risk of hypertension in obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Significance of biomarkers for metabolic syndrome during weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The adipocyte as an endocrine cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Impact of the renin-angiotensin system on lipid and carbohydrate metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Weight loss and the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Human adipocytes secrete mineralocorticoid-releasing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The heart in obesity-hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Current status and perspectives in ceramide-targeting molecular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Inhibitory effect of ceramide on insulin-induced protein kinase Czeta translocation in rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Ceramide content is increased in skeletal muscle from obese insulin-resistant humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Exercise and training effects on ceramide metabolism in human skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Cholesteryl ester transfer protein gene expression during differentiation of human preadipocytes to adipocytes in primary culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Torcetrapib/atorvastatin combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Fatty acid mobilization from adipose tissue during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Hormone-sensitive lipase--new roles for an old enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Differences in the expression of lipolytic-related genes in rat white adipose tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The biology of white adipocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Are the metabolic effects of GH and IGF-I separable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of gastric bypass on the GH/IGF-I axis in severe obesity--and a comparison with GH deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Does high-intensity resistance training maintain bone mass during moderate weight loss in older overweight adults with type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Rethinking leptin and insulin action: therapeutic opportunities for diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of leptin, acetylcholine and vasoactive intestinal polypeptide on insulin secretion in isolated ob/ob mouse pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Analysis of paradoxical observations on the association between leptin and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Leptin Fully Suppresses Acetylcholine-Induced Insulin Secretion and is Reversed by Tolbutamide in Isolated Perfused Chicken Pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Role of leptin in blood pressure regulation and arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Leptin-replacement therapy for lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Triglycerides induce leptin resistance at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Weight loss favorably modifies anthropometrics and reverses the metabolic syndrome in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The role of diet and exercise for the maintenance of fat-free mass and resting metabolic rate during weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Postprandial triglyceride response in visceral obesity in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The effects of weight loss on the activity and expression of adipose-tissue lipoprotein lipase in very obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Regulation of lipolysis and lipoprotein lipase after weight loss in obese, postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Hormone sensitive lipase expression and adipose tissue metabolism show gender difference in obese subjects after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Perilipin targets a novel pool of lipid droplets for lipolytic attack by hormone-sensitive lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Perilipin expression in human adipose tissues: effects of severe obesity, gender, and depot

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Obese subjects carrying the 11482G>A polymorphism at the perilipin locus are resistant to weight loss after dietary energy restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Glyceroneogenesis comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The impact of phospholipid transfer protein (PLTP) on HDL metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Influence of obesity and insulin sensitivity on phospholipid transfer protein activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The determinants of plasma plasminogen activator inhibitor-1 levels differ for American and Japanese men aged 40-49.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Plasminogen activator inhibitor-1 modulates adipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effect of low-calorie diets on plasma retinol-binding protein concentrations in overweight women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Sex hormones and sexual function in obese men losing weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The effect of weight loss on reproductive hormones in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Obesity and weight loss in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

TNF-alpha inhibits glucose-induced insulin secretion in a pancreatic beta-cell line (INS-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Pharmacotherapy for dyslipidaemia – current therapies and future agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Orlistat for obesity: benefits beyond weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Brain-adipose tissue cross talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Metabolic and hormonal interactions between muscle and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Proteolytic and lipolytic responses to starvation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Regional adipocity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Relationship between serum adiponectin and leptin concentrations and body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

A paradox resolved: the postprandial model of insulin resistance explains why gynoid adiposity appears to be protective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The role of the novel adipocyte-derived hormone adiponectin in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

A review of the metabolic effects of sibutramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The effect of orlistat-induced weight loss on interleukin-6 and C-reactive protein levels in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The anti-obesity effect of rimonabant is associated with an improved serum lipid profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Visfatin is an adipokine, but it is not regulated by thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Overestimation of plasma nonesterified fatty acid concentrations in heparinized blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Reduced production rates of testosterone and dihydrotestosterone in healthy men treated with rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.871

21 January 2018

Identifiers

DOI

10.1586/14779072.4.6.871

1 reference

3 August 2017

1 reference